Prior to its formation, Trichome Pharma joins the European Industrial Hemp Association (EIHA), making it one of the first members from Spain.
Trichome Pharma completes its first capital raise led by Trichome Capital and other trusted investors. Key management personnel are hired to help the company take its first steps.
Trichome Pharma completes a successful hemp harvest on its organic-certified farm in northern Spain.
AEMPS grants Trichome Pharma authorization to cultivate cannabis for research purposes.
Labiana Pharmaceuticals and Little Green Pharma join as shareholders and strategic partners.
Trichome Pharma’s commitment to research and technological development is recognized by major public institutions. Our first medicinal cannabis research project: “Investigación de las estrategias y rendimiento de cultivo de variedades de Cannabis Sativa L. y de la optimización y control de calidad de sus principios farmacológicamente activos” (IDI-20220976) has been co-financed by the European Regional Development Fund (ERDF 2021-2027) and by the Center for Industrial Technological Development (CDTI).